Omnicell, Inc. (OMCL)
NASDAQ: OMCL · Real-Time Price · USD
48.89
+0.03 (0.06%)
Nov 12, 2024, 4:00 PM EST - Market closed

Omnicell Revenue

Omnicell had revenue of $282.42M in the quarter ending September 30, 2024, a decrease of -5.44%. This brings the company's revenue in the last twelve months to $1.06B, down -10.26% year-over-year. In the year 2023, Omnicell had annual revenue of $1.15B, down -11.48%.

Revenue (ttm)
$1.06B
Revenue Growth
-10.26%
P/S Ratio
2.11
Revenue / Employee
$291,563
Employees
3,650
Market Cap
2.26B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.15B-148.84M-11.48%
Dec 31, 20221.30B163.93M14.48%
Dec 31, 20211.13B239.81M26.88%
Dec 31, 2020892.21M-4.82M-0.54%
Dec 31, 2019897.03M109.72M13.94%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Ardent Health Partners 5.71B
Astrana Health 1.72B
Premier 1.33B
CONMED 1.29B
Addus HomeCare 1.13B
Warby Parker 742.53M
Amphastar Pharmaceuticals 723.55M
LeMaitre Vascular 213.03M
Revenue Rankings